• Home
  • High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS.

High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS.

Author List
Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Steinmiller KC, Griffith LM, Muraro PA, Openshaw H, Sayre PH, Stuve O, Arnold DL, Wener MH, Georges GE, Wundes A, Kraft GH, Bowen JD
Publication
Neurology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1208463
Publication Year
2017
PubMed ID
28148635
Publication Title
Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Steinmiller KC, Griffith LM, Muraro PA, Openshaw H, Sayre PH, Stuve O, Arnold DL, Wener MH, Georges GE, Wundes A, Kraft GH, Bowen JD. High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS. Neurology. 2017 Feb 28; 88(9):842-852.